Denali Therapeutics Inc. <DNLI.O>: B. Riley raises target price to $35 from $30
DNLI•Related News
Nexstar Chief Technology and Digital Officer Brett Jenkins retires Oct. 1, shifts to executive advisor
NXST•
AtlasClear rebrands correspondent clearing unit Wilson-Davis as AtlasClearing
ATCH•
Nutanix, Inc. <NTNX.O>: UBS Raises Target Price to $80 From $62
NTNX•
FalconStor launches Clarity AI-powered selling platform for channel partners
FALC•
Canada's Senstar Technologies Q2 revenue rises on LiDAR growth
SNT•